Beximco Pharma has declared 35pc cash dividend for the financial year ended June 30, 2022, after reviewing and approving the financial report for the third quarter of the current financial year at the meeting of the company’s board of directors held on Thursday (October 27).
According to the financial report of the completed financial year, the earnings per share (EPS) of the company is 11 taka 48 paisa. Earnings per share (EPS) was Tk 11.49 paisa in the corresponding period last fiscal.
The company’s NAV per share (NAVPS) at the end of June 30, 2022 stood at Tk 91.01 paisa, the firm will hold the Annual General Meeting (AGM) on December 22 to approve this dividend. The record date for this has been fixed on November 21.
Share this
